Sciety and Sciety Venture Partners invest EUR 5.3 million in Capitainer
Sciety and Sciety Venture Partners recently completed an investment of EUR 5.3 million in Capitainer, a Swedish medtech company that has developed a unique platform for self-sampling of blood, facilitating remote healthcare solutions and personalized medicine. The capital will be used for sales & marketing and expanding production capacity to establish Capitainer as a leading supplier of self-sampling solutions with market-leading clinical accuracy.Capitainer's platform allows people to collect blood samples from their fingertips, anytime and anywhere, and send the samples by regular mail